ATS 2018 International Conference

Contribution of Asthma Control Test (ACT) Total Score ≥20 or Improvement from Baseline ≥3 to the Composite Primary Effectiveness Endpoint in the Salford Lung Study in Asthma (SLS Asthma) [Board No. P880]

Location: Board no. P880

Session Type: Thematic Poster Session

Sunday

May

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Jorgen Vestbo

MD, PhD
Manchester Academic Health Sciences Centre, The University of Manchester and Manchester University N;Manchester Academic Health Sciences Centre, The University of Manchester and University Hospital So

Susan D. Collier

BSc, MBchB
GlaxoSmithKline;GSK

Nawar Diar Bakerly

MD, FRCP
Salford Royal NHS Foundation Trust & Manchester Academic Health Sciences Centre, The University of M

Lucy Frith

MSc
GSK

Henrik Svedsater

PhD
GSK

Joanne Fletcher

PhD
GSK

John P. New

MB, BS, FRCP
Salford Royal NHS Foundation Trust and NorthWest EHealth;Salford Royal NHS Foundation Trust, Salford and NorthWest EHealth

Ashley A. Woodcock

MD
Manchester Academic Health Sciences Centre, The University of Manchester and Manchester University N;Manchester Academic Health Sciences Centre, University of Manchester and Manchester University NHS

Neil Barnes

MD
GSK

Loretta Jacques

BSc, PhD
GlaxoSmithKline;GSK

View Abstract

Contribution of Asthma Control Test (ACT) Total Score ≥20 or Improvement from Baseline ≥3 to the Composite Primary Effectiveness Endpoint in the Salford Lung Study in Asthma (SLS Asthma)

Parent Sessions

A34 - ASTHMA CLINICAL STUDIES I
05-20-2018 9:15 AM - 4:15 PM

Event